Adjuvant radiation therapy in metastatic lymph nodes from melanoma
2011

Adjuvant Radiation Therapy for Melanoma

Sample size: 86 publication Evidence: moderate

Author Information

Author(s): Bibault Jean-Emmanuel, Dewas Sylvain, Mirabel Xavier, Mortier Laurent, Penel Nicolas, Vanseymortier Luc, Lartigau Eric

Primary Institution: CLCC Oscar Lambret Comprehensive Cancer Center, Lille-Nord de France University

Hypothesis

Can adjuvant radiation therapy improve outcomes for patients with metastatic lymph nodes from melanoma?

Conclusion

Adjuvant radiotherapy was able to increase regional control in a targeted sub-population with lymph nodes showing extracapsular extension.

Supporting Evidence

  • Patients with extracapsular extension treated with surgery followed by radiation therapy had better regional control than those with lower doses.
  • The median survival after lymph node recurrence was 31.8 months.
  • Radiation therapy did not improve overall survival but did improve regional control for certain patients.

Takeaway

This study looked at how radiation therapy helps patients with melanoma that has spread to lymph nodes. It found that radiation can help control the cancer better, especially for certain patients.

Methodology

A retrospective analysis of 86 patients treated with lymphadenectomy and radiation therapy, assessing outcomes based on treatment regimens.

Potential Biases

Potential selection bias due to the retrospective nature of the study.

Limitations

The study is unicentric and retrospective, which may limit the generalizability of the results.

Participant Demographics

The cohort consisted of 86 patients, with a median age of 51 years, including 57 men.

Statistical Information

P-Value

p = 0.004

Confidence Interval

95% CI 23.3 to 40.3 months

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1748-717X-6-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication